about
Ethionamide boosters. 2. Combining bioisosteric replacement and structure-based drug design to solve pharmacokinetic issues in a series of potent 1,2,4-oxadiazole EthR inhibitorsComparative study of vascular prostheses coated with polycyclodextrins for controlled ciprofloxacin release.Alginate-poloxamer microparticles for controlled drug delivery to mucosal tissue.Methyl-β-cyclodextrin modified vascular prosthesis: Influence of the modification level on the drug delivery properties in different media.MALDI-TOF MS imaging of controlled release implants.Mathematical modeling of bioerodible, polymeric drug delivery systems.Drug delivery to the upper small intestine window using gastroretentive technologies.Higuchi equation: derivation, applications, use and misuse.Modeling of diffusion controlled drug delivery.Stability of aqueous polymeric controlled release film coatings.In-silico simulations of advanced drug delivery systems: what will the future offer?Understanding and predicting drug delivery from hydrophilic matrix tablets using the "sequential layer" model.Gentamicin-loaded poly(lactic-co-glycolic acid) microparticles for the prevention of maxillofacial and orthopedic implant infections.HPMC-matrices for controlled drug delivery: a new model combining diffusion, swelling, and dissolution mechanisms and predicting the release kinetics.The 6th world meeting on pharmaceutics, biopharmaceutics and pharmaceutical technology (PBP meeting) April 7-10, 2008, Barcelona, Spain.Enzymatically degraded Eurylon 6 HP-PG: ethylcellulose film coatings for colon targeting in inflammatory bowel disease patients.Influence of urea and guanidine hydrochloride on lysozyme stability and thermal denaturation; a correlation between activity, protein dynamics and conformational changes.For the special IJP issue "poorly soluble drugs".Calculation of the dimensions of dosage forms with release controlled by diffusion for in vivo use.Floating microparticles based on low density foam powder.The effect of gamma-irradiation on drug release from bioerodible microparticles: a quantitative treatment.Floating matrix tablets based on low density foam powder: effects of formulation and processing parameters on drug release.Non-degradable microparticles containing a hydrophilic and/or a lipophilic drug: preparation, characterization and drug release modeling.Multiple unit gastroretentive drug delivery systems: a new preparation method for low density microparticles.Quaternary polymethacrylate-magnesium aluminum silicate films: molecular interactions, mechanical properties and tackiness.Polymer blends used for the aqueous coating of solid dosage forms: importance of the type of plasticizer.Characterization of ethylcellulose: starch-based film coatings for colon targeting.Novel polymeric film coatings for colon targeting: Drug release from coated pellets.Development of injection moulded matrix tablets based on mixtures of ethylcellulose and low-substituted hydroxypropylcellulose.Drug release from MCC- and carrageenan-based pellets: experiment and theory.Colon targeting with bacteria-sensitive films adapted to the disease state.Fenofibrate-loaded PLGA microparticles: effects on ischemic stroke.pH-Sensitive polymer blends used as coating materials to control drug release from spherical beads: elucidation of the underlying mass transport mechanisms.In vivo efficacy of microbiota-sensitive coatings for colon targeting: a promising tool for IBD therapy.How to improve the storage stability of aqueous polymeric film coatings.Calculation of the required size and shape of hydroxypropyl methylcellulose matrices to achieve desired drug release profiles.Effect of the size of biodegradable microparticles on drug release: experiment and theory.Preparation and investigation of P28GST-loaded PLGA microparticles for immunomodulation of experimental colitis.In vitro and in vivo behavior of ground tadalafil hot-melt extrudates: How the carrier material can effectively assure rapid or controlled drug release.PLGA implants: How Poloxamer/PEO addition slows down or accelerates polymer degradation and drug release.
P50
Q27675647-E89B3901-5F35-4AB9-BF7A-21FC6D4ED366Q30560920-DA326D20-9C18-4E97-B904-8E1F0A097B08Q33397891-0B6D5A32-B528-43D4-9865-BE54F717EFB5Q33690210-1968CF37-6BA6-4904-B412-7694CA131F12Q34253893-CD96E7C6-BFCA-4BDE-BA69-139BEE6ADF6CQ34258366-62AAC7CB-6482-47F4-B618-D4F8C990EF2FQ36556905-4BC9C3F6-F97A-44C4-85B7-877A222DB568Q37860531-2E36077E-3D09-4D92-BCC5-8B7D556362ADQ37948460-8B153DE8-2353-4FA9-A184-9EA1DD3F32DFQ38152566-F2A9CD1C-33F3-4393-A8FC-C9DE51BE862CQ39381672-F834BE7B-F034-4D02-AE8B-D6717C8A7409Q40648435-697A9CFC-CA40-40A2-9E7F-4BD193F5C87BQ40694426-0F26245B-529A-4B68-924A-307F6281D006Q40788990-03D842BB-A307-4F3F-8970-AC36767CFEAAQ42373992-DCB8D23F-F4D1-4361-B122-4111AFBEDF11Q42835476-F28D45E6-5201-4970-9CF4-168ABD0CF336Q42916083-861A18AD-6096-4337-88CF-93909C8A8977Q43447130-78274D91-02BC-4E9C-9AC7-72C5053529EBQ43518452-1E15A5EF-16C9-4224-B639-C278B9BA9B06Q44052292-181BD333-90AD-475A-8661-1BF84701A7CBQ44101001-15E5F0FF-5B98-4E51-8096-5C1EE86C09E1Q44294260-4944F8E4-A448-426F-BA77-83EF6CA629C0Q44367045-79ED83A6-9C18-4F99-B73A-CC9844F55026Q44525763-C94B92B1-85E9-4738-B524-78BB4363ADF4Q44535260-E75685CD-EBFA-47E1-BA97-ECCB54E839A0Q45040598-2067189E-D79A-421F-900D-AAD55FF4661EQ45040598-AC8142A3-4FD4-4027-86A5-108B6BD217A4Q45953225-5793E642-CAAD-4804-8298-F2ABEDC9CAF3Q45985454-14A730F0-FC47-4BA7-A788-AF74F5136FD1Q45985500-CC7F520F-7182-4A16-AC21-8480BFCB12F5Q45998917-440F9246-BF8F-46D3-9AAC-3009C311622AQ46030256-5E7C3069-F25A-4F72-8A0B-F5605AA25073Q46148253-7AD3B49E-2A18-441E-94C7-E6E236B5CCF4Q46607432-62E0DC0D-3076-49B3-89AE-030F5C75E623Q46607432-65102D81-13A1-43B5-A1BE-D6602203AD34Q46807562-8420C3C1-FAC4-4C75-A891-7EE9DAA6EAB1Q46859183-E0A4BB77-2577-48F2-8AB7-3952B4AEC5DEQ47235523-F62F1BAC-937F-49D1-9DC6-C0EFCD746B6CQ47423809-A608359E-1B89-45E6-BE16-D4A534A91DD1Q47782667-922ADFF2-0259-4F6D-B3B8-BDBA0493406C
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
ricercatore
@it
հետազոտող
@hy
name
Juergen Siepmann
@ast
Juergen Siepmann
@en
Juergen Siepmann
@es
Juergen Siepmann
@nl
Juergen Siepmann
@sl
type
label
Juergen Siepmann
@ast
Juergen Siepmann
@en
Juergen Siepmann
@es
Juergen Siepmann
@nl
Juergen Siepmann
@sl
prefLabel
Juergen Siepmann
@ast
Juergen Siepmann
@en
Juergen Siepmann
@es
Juergen Siepmann
@nl
Juergen Siepmann
@sl
P214
P244
P1053
M-5788-2015
P106
P1153
13105443900
P21
P214
P244
n2009180311
P31
P3829
P3835
juergen-siepmann
P496
0000-0001-9058-0579
P734
P7859
lccn-n2009180311